Imiquimod a new adjuvant for telomerase peptide vaccine: A phase I trial in patients with inoperable pancreatic cancer.

被引：0
|
作者：
Bernhardt, SL
Buanes, TA
Moller, M
Eriksen, JA
Geudernack, G
机构：
[1] Univ Oslo, Ullevaal Hosp, N-0407 Oslo, Norway
[2] Gemvax, Porsgrunn, Norway
[3] Norwegian Radium Hosp, Oslo, Norway
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：867S / 867S
页数：1
相关论文
共 50 条
  • [21] Phase I trial of gemcitabine in patients with advanced pancreatic cancer
    Okada, S
    Ueno, H
    Okusaka, T
    Ikeda, M
    Furuse, J
    Maru, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (01) : 7 - 12
  • [22] Dendritic cell tumor fusions as a novel tumor vaccine: A phase I trial for patients with metastatic breast cancer.
    Avigan, D
    Gong, JL
    Uhl, L
    Wu, ZK
    Vasir, D
    Smith, T
    Borges, V
    Atkins, M
    Stone, C
    Giallombardo, N
    Schadt, K
    Tetreault, JC
    Kufe, D
    BLOOD, 2001, 98 (11) : 14A - 14A
  • [23] Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma
    Balachandran, Vinod P.
    Rojas, Luis A.
    Sethna, Zachary
    Soares, Kevin
    Derhovanessian, Evelyna
    Mueller, Felicitas
    Yadav, Mahesh
    Basturk, Olca
    Gonen, Mithat
    Wei, Alice Chia-Chi
    D'Angelica, Michael Ian
    Kingham, T. Peter
    Greenbaum, Benjamin
    Merghoub, Taha
    Jarnagin, William R.
    Drebin, Jeffrey A.
    Sahin, Ugur
    Tuereci, Oezlem
    Wolchok, Jedd D.
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] A phase I trial of cabozantinib (XL184) and gemcitabine in advanced pancreatic cancer.
    Zhen, David Bing
    Griffith, Kent A.
    Ruch, Joshua Michael
    Morgan, Meredith
    Kim, Edward Jae-hoon
    Sahai, Vaibhav
    Simeone, Diane M.
    Zalupski, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [25] A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer.
    Neuhaus, P
    Oettle, H
    Post, S
    Gellert, K
    Ridwelski, K
    Schramm, H
    Zülke, C
    Fahlke, G
    Langrehr, J
    Riess, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1092S - 1092S
  • [26] Phase I trial of patupilone plus carboplatin in patients with advanced cancer.
    Gore, M
    Kaye, S
    Oza, A
    Keyzor, C
    Pyle, L
    Pereno, R
    Sklenar, I
    Zaknoen, S
    Johri, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 476S - 476S
  • [27] Phase I clinical trial of lenalidomide with temsirolimus in patients with advanced cancer.
    Ganesan, Prasanth
    Piha-Paul, Sarina Anne
    Naing, Aung
    Falchook, Gerald Steven
    Wheler, Jennifer J.
    Janku, Filip
    Zinner, Ralph
    Laday, Shell
    Kies, Merrill S.
    Tsimberidou, Apostolia Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Phase I trial of lenalidomide and valproic acid in patients with advanced cancer.
    Bilen, Mehmet A.
    Fu, Siqing
    Hong, David S.
    Wheler, Jennifer J.
    Abdelrahim, Maen
    Falchook, Gerald S.
    Tsimberidou, Apostlia M.
    Janku, Filip
    Piha-Paul, Sarina
    Zinner, Ralph
    Kurzrock, Razelle
    Naing, Aung
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [29] A phase I and pharmacokinetic study of capecitabine in combination with radiotherapy in patients with localised inoperable pancreatic cancer
    Roxburgh, Patricia
    Lumsden, Graeme R.
    Paul, James
    Harden, Sharon
    Sweeting, Lorna
    James, Allan
    Crellin, Adrian
    Morrison, Rosemary
    Evans, T. R. Jeffry
    McDonald, Alexander C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 131 - 139
  • [30] A phase I and pharmacokinetic study of capecitabine in combination with radiotherapy in patients with localised inoperable pancreatic cancer
    Patricia Roxburgh
    Graeme R. Lumsden
    James Paul
    Sharon Harden
    Lorna Sweeting
    Allan James
    Adrian Crellin
    Rosemary Morrison
    T. R. Jeffry Evans
    Alexander C. McDonald
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 131 - 139
12345